Trials / Completed
CompletedNCT02014519
A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary
Seroprevalence of Bordetella Pertussis in Adults in Hungary
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,000 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to perform an epidemiological survey of the adult population in Hungary to calculate the seroprevalence of pertussis.
Detailed description
The protocol posting was amended to correct the detailed title. Since a sample of blood will be collected from all subjects (outside of routine hospital procedure), the study does not meet GSK's definition of an observational study and hence the term "observational" was deleted from the detailed title.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sampling | A blood sample (2.5 mL) will be collected from all subjects |
| OTHER | Data collection | Active questioning |
Timeline
- Start date
- 2014-04-24
- Primary completion
- 2015-04-22
- Completion
- 2015-04-24
- First posted
- 2013-12-18
- Last updated
- 2019-11-26
- Results posted
- 2018-12-17
Locations
5 sites across 1 country: Hungary
Source: ClinicalTrials.gov record NCT02014519. Inclusion in this directory is not an endorsement.